Soluplus®-Based Pharmaceutical Formulations: Recent Advances in Drug Delivery and Biomedical Applications
International Journal of Molecular Sciences · 11.02.2025 · 26 (4) · 1499
DOI: 10.3390/ijms26041499 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 11.02.2025. Verfasst von Nerea Guembe-Michel und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, School of Science, University of Navarra, 31080 Pamplona, Spain. Hauptthemen laut MEDLINE: Polyethylene Glycols, Polyvinyls, Drug Delivery Systems, Drug Compounding. Die Arbeit wurde bisher 49-mal zitiert (Crossref) und nennt 148 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministerio de Ciencia, Innovación y Universidades, Fundación La Caixa, Fundación Roviralta (Chair "Maria Francisca de Roviralta of Molecu-lar Parasitology, Leishmani-asis and One Health").
Abstract (Originalsprache)
Poor water solubility remains a significant challenge in the pharmaceutical industry that limits the therapeutic efficacy and bioavailability of many active pharmaceuticals. Soluplus® (SLP), an amphiphilic graft copolymer made of polyethylene glycol, polyvinyl caprolactam, and polyvinyl acetate, has been gaining interest in recent years as it addresses these limitations by acting as a versatile carrier. Its ability to form stable amorphous dispersions and enhance drug solubility, as well as its physicochemical properties, support its role as a key excipient in advanced drug delivery systems. Recent investigations have demonstrated the adaptability of SLP in addressing drug delivery requirements, offering controlled release, improved targeting, and superior therapeutic outcomes. This review examines some key formulation methods that make use of SLP, including hot-melt extrusion, spray drying, electrospinning, drug–polymer layering, and capsule and tablet formulations, highlighting the capacity of SLP to overcome formulation challenges. Biomedical applications of SLP have also been explored, with a focus on its role in improving the delivery of antitumoral, anti-inflammatory, antimicrobial, and antiparasitic drugs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Chemistry, School of Science, University of Navarra, 31080 Pamplona, Spain.
- Department of Microbiology and Parasitology, Navarra Institute for Health Research (IdisNA), University of Navarra, 31080 Pamplona, Spain.
ORCID-Profile: Nerea Guembe-Michel, Paul Nguewa, Gustavo González-Gaitano
Förderung
- Ministerio de Ciencia, Innovación y Universidades
- Fundación La Caixa
- Fundación Roviralta (Chair "Maria Francisca de Roviralta of Molecu-lar Parasitology, Leishmani-asis and One Health")
- Ministerio de Ciencia e Innovación
Zitieren
APA
Guembe-Michel, N., Nguewa, P., & González-Gaitano, G. (2025). Soluplus®-Based Pharmaceutical Formulations: Recent Advances in Drug Delivery and Biomedical Applications. International Journal of Molecular Sciences, 26(4), 1499. https://doi.org/10.3390/ijms26041499
Vancouver
Guembe-Michel N, Nguewa P, González-Gaitano G. Soluplus®-Based Pharmaceutical Formulations: Recent Advances in Drug Delivery and Biomedical Applications. International Journal of Molecular Sciences. 2025;26(4):1499. doi:10.3390/ijms26041499
BibTeX
@article{GuembeMichel2025,
author = {Guembe-Michel, Nerea and Nguewa, Paul and González-Gaitano, Gustavo},
title = {Soluplus®-Based Pharmaceutical Formulations: Recent Advances in Drug Delivery and Biomedical Applications},
journal = {International Journal of Molecular Sciences},
year = {2025},
volume = {26},
number = {4},
pages = {1499},
doi = {10.3390/ijms26041499}
}
EUVIMED